Valuation: Abbott Laboratories

Market Cap 192B 166B 156B 142B 267B 18,305B 271B 1,832B 716B 9,165B 721B 705B 30,562B P/E 2026 *
31.8x
P/E 2027 * 24.5x
Enterprise Value 216B 187B 175B 160B 300B 20,588B 305B 2,061B 806B 10,309B 810B 793B 34,374B EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.9x
Free-Float
86.16%
Yield 2026 *
2.32%
Yield 2027 * 2.47%
1 day+1.08%
1 week+4.92%
Current month+4.93%
1 month+18.08%
3 months+31.49%
6 months-0.50%
Current year-11.48%
1 week 106.01
Extreme 106.01
111.28
1 month 87.64
Extreme 87.64
111.28
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

416 0.0000%
30/06/26 Free

Director

432 0.0000%
30/06/26 Free

Director

363 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+4.92%-15.35%+5.32% 190B
+0.09%+5.55%-1.43%+8.76% 116B
-5.90%-0.96%+8.65%+67.67% 63.71B
+2.36%+4.47%+34.22%+64.95% 55.13B
+1.20%+7.57%-5.84%-34.97% 49.41B
+1.42%+9.85%+13.26%-18.70% 33.79B
+1.31%-3.18% - - 30.74B
+0.26%+0.36%+46.85%-10.75% 24.73B
+1.04%+13.56%-6.08%+23.70% 23.85B
-0.68%+1.67%-2.94%+3.77% 23.23B
Average +0.21%+4.18%+7.93%+12.19% 61.05B
Weighted average by Cap. +0.21%+4.39%+0.80%+13.71%

Financials

2026 *2027 *
Net sales 50.3B 43.58B 40.84B 37.25B 70.02B 4,798B 71.1B 480B 188B 2,402B 189B 185B 8,011B 54.65B 47.35B 44.36B 40.46B 76.07B 5,212B 77.24B 522B 204B 2,610B 205B 201B 8,703B
Net income 6.23B 5.4B 5.06B 4.61B 8.67B 594B 8.81B 59.49B 23.25B 298B 23.39B 22.88B 992B 7.93B 6.87B 6.44B 5.87B 11.04B 757B 11.21B 75.75B 29.61B 379B 29.79B 29.14B 1,263B
Net Debt 23.94B 20.74B 19.43B 17.72B 33.32B 2,283B 33.84B 229B 89.34B 1,143B 89.88B 87.93B 3,812B 20.96B 18.16B 17.01B 15.52B 29.17B 1,999B 29.62B 200B 78.21B 1,001B 78.69B 76.98B 3,337B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
12/08/26 US$110.91 +1.08% 6,613,508
11/08/26 US$109.72 +1.01% 6,744,803
10/08/26 US$108.62 +0.75% 5,603,218
07/08/26 US$107.81 -0.14% 6,606,637
06/08/26 US$107.96 +2.13% 9,801,625
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
110.91USD
Average target price
118.42USD
Spread / Average Target
+6.77%

Quarterly revenue - Rate of surprise